Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits

• المؤلفون الرئيسيون: Abigail S. Zamorano (مؤلف), Leping Wan (مؤلف), Matthew A. Powell (مؤلف), L. Stewart Massad (مؤلف)
• التنسيق: كتاب
• منشور في: Elsevier, 2017-11-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Our objective was to assess overall survival of cervical cancer patients following prior platinum/bevacizumab chemotherapy, comparing retreatment with platinum/bevacizumab with alternative therapies. A retrospective analysis was performed of women who received platinum/bevacizumab (PB) chemotherapy...